pharmapress.co.uk | The latest pharmaceutical industry news

Pharma Lab news

SLAS celebrates innovative new products, startups and scientific excellence at European conference in Vienna

Funding & Finance

GSK enters agreement to acquire Nuvalent for US$10.6 billion

Pharma Lab products

Medable launches Agentic accelerator programme to help life sciences companies deploy agentic AI across clinical lifecycle

Pharma Lab products

Cubis III: compliant weighing, direct integration, and scalable connectivity, without extra software

Drug Discovery and Development

Medable launches Agentic accelerator programme to help life sciences companies deploy agentic AI across clinical lifecycle

Medable, a leading technology platform for agentic AI-powered clinical development, has announced its Agentic accelerator programme to help life sciences companies transform clinical development with...

New study reveals promising new way to find serious liver disease earlier

Predictive Health Intelligence has announced a promising new way to identify people with serious liver disease earlier, using existing NHS blood test data. The findings...

Development of investigational Ebola vaccines to be accelerated

The Coalition for Epidemic Preparedness Innovations (CEPI) has announced that it will urgently accelerate the development of three investigational vaccines targeting the Bundibugyo ebolavirus...

Levicept presented data at EULAR 2026 suggesting Levi-04 may modify disease in osteoarthritis

Levisept, a biotechnology company focused on the development of Levi-04, a first-in-class treatment for osteoarthritis (OA), presented key data from its phase 2 study...

Northway Biotech to expand global ATMP manufacturing with €61m Vilnius facility

The most advanced cell therapy infrastructure in the Baltic region is being developed in Vilnius. Northway Biotech, a leading protein-based biologics and ATMPs CDMO, is...

MEKanistic Therapeutics announces FDA clearance of IND for MTX-531, enabling phase 1 trials in advanced solid tumours

MEKanistic Therapeutics, a biotechnology company developing first-in-class precision medicines designed to overcome cancer resistance mechanisms, has announced that the US Food and Drug Administration...

Matter Bio files first IND for Lm-LLO-TT, advancing first-in-human phase 1/2a study in patients with pancreatic cancer

Matter Bio has submitted its first Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for Lm-LLO-TT, the company's lead therapeutic candidate,...

Atossa Therapeutics announces acceptance of manuscript highlighting utrophin-modulation potential of (Z)-Endoxifen in Duchenne Muscular Dystrophy

Atossa Therapeutics, a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of significant unmet clinical need, has announced that a manuscript...

Innovent Biologics’ new bispecific fusion protein demonstrates robust survival benefits in long-term follow-up study in advanced immunotherapy-resistant non-small-cell lung cancer

Innovent Biologics has announced updated data from the phase 1 clinical study of its first-in-class PD-1/IL-2α-bias bispecific fusion protein IBI363 in the treatment of advanced...

US FDA IND clearance for localised fat reduction candidate, a second global phase 3 study of Caliway’s CBL-514

The Investigational New Drug (IND) application for CBL-0302 (Supreme-02), Caliway's second multi-country pivotal phase 3 study for its localised fat reduction candidate CBL-514, has...

Neuvoir awarded Smart:Scotland grant to advance AI feasibility work for NHS generic medicines access

Neuvoir Pharmaceuticals has been awarded over £99,000 in Smart:Scotland funding from Scottish Enterprise to support the development of Pharmoris®, its AI-enabled medicines intelligence and...

Oxford University scaling doses of Ebolavirus candidate vaccine

In response to the current Bundibugyo Ebolavirus outbreak in the Democratic Republic of the Congo, the Oxford Vaccine Group (OVG) is working urgently with...

Navamedic launches Virono – a single-dose over-the-counter cold sore tablet

Navamedic ASA has launched Virono®, an over-the-counter (OTC) single-dose treatment for recurrent cold sores (herpes labialis) in adults. The launch establishes a new OTC treatment category...

Lupin receives China approval for Oseltamivir phosphate oral suspension

Global pharma major Lupin has announced that China's National Medical Products Administration has approved its abbreviated new drug application for oseltamivir phosphate, in partnership...

Ojemda approved in the European Union as the first targeted therapy in relapsed or refractory paediatric low-grade glioma

The European Commission (EC) has granted conditional marketing authorisation for Ojemda® (tovorafenib) as monotherapy for the treatment of patients six months of age and older...

CARBOGEN AMCIS Shanghai site achieves successful outcome in unannounced NMPA GMP inspection

CARBOGEN AMCIS, a Switzerland-based pharmaceutical process development and active pharmaceutical ingredient (API) manufacturing company, today announces its Shanghai facility has successfully completed an unannounced...

BioLife Solutions wins Interphex 2026 biotech innovation award for CellSeal CryoCase

BioLife Solutions, a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) market, has received the Interphex...

US$ 8.5 million investment in malaria and other R&D projects planned among pharma giants

The global health innovative technology (GHIT) fund has announced a total investment of approximately JPY 1.37 billion (US$ 8.5 million) in five R&D projects...

New non-compromise early-phase progression accelerator launched

CARBOGEN AMCIS introduces Sprint for early-phase development, a new, phase-appropriate approach designed to accelerate early-phase progression while maintaining scientific rigour. Sprint has been designed to...

Dayspring Pharma announces phase 2 trial of CG2001 foam met primary endpoint in Chinese adult men with androgenetic alopecia

Dayspring Pharma has announced top-line data from its phase 2 clinical trial of CG2001 foam in male patients with androgenetic alopecia (AGA). The trial met...

Clinical Trials Insight

New drug applications for Bayer’s FXIa inhibitor accepted by US Food and Drug Administration under priority review and by Japan’s Ministry of Health, Labour...

Bayer has announced that the US Food and Drug Administration (FDA) and Japan’s Ministry of Health, Labour and Welfare have accepted the company’s New...

New analysis shows Tryngolza (olezarsen) reduced acute pancreatitis by 85% and triglycerides by 66% in severe hypertriglyceridemia

Sobi has announced results from a new analysis of the pivotal phase 3 trials, showing Tryngolza® (olezarsen) reduced the relative risk of acute pancreatitis...

BioLineRx and Hemispherian announce new data demonstrating potent anti-tumour effect in Glioblastoma (GBM) across multiple in vivo studies

BioLineRx, a clinical development stage biopharmaceutical company, and Hemispherian, a clinical-stage oncology company developing novel small molecule therapeutics, have announced highly encouraging new preclinical...

Orexo announces positive outcome from in vivo study of OX390

Orexo AB has announced positive data from a pre-clinical in vivo study on the nasal absorption of atipamezole when delivered with Orexo's AmorphOX® drug...

Myosin Therapeutics initiates phase 1/2 trial of MT-125 targeting non-muscle myosin II in newly diagnosed glioblastoma

Myosin Therapeutics, a clinical stage biotechnology company developing innovative therapies for oncology, has announced that the first patient has been dosed in its phase...

VIDEOS

Technology and Automation

Next-generation cryogenic transmission electron microscope –Glacios 3 Cryo-TEM launched

Videos

Abselion strengthens global position in cell and gene therapy through specialist analytical and process technologies

Videos

Bridging the gap from discovery to scale: the shift to absolute precision in cell and gene therapy

Videos

Scaling Cell and Gene Therapies: how AI, automation and workforce trends are shaping sample management

Videos

How automation is improving reliability in NGS sample preparation

Videos

Ilmac Lausanne 2026: everything you need to know

Videos

Cell & Gene Therapy 2026: all you need to know

Conferences and events

American Biomanufacturing Summit 2026

Pharma in Healthcare

IBSA foundation fellowships shatter records with unprecedented global reach and opens 2026 call

IBSA Foundation (Institut Biochimique SA) for scientific research, recently announced a record-shattering year for its prestigious fellowship programme, drawing an unprecedented 398 applications from 64 countries....

Acute myocardial infarction market is expected to hit growth stride at a CAGR of 13% during the forecast period (2026-2036) with new therapeutic innovations

Recently published acute myocardial infarction market insights report includes a comprehensive understanding of current treatment practices, acute myocardial infarction emerging drugs, market share of...

Charcot-Marie-Tooth disease market growth to accelerate significantly during the forecast period (2026-2036) driven by the launch of emerging disease-modifying therapies

Recently published Charcot–Marie–Tooth Disease Market Insights report includes a comprehensive understanding of current treatment practices, Charcot–Marie–Tooth disease emerging drugs, market share of individual therapies,...

Tyra Biosciences and the Bladder Cancer Advocacy Network have established 21 May as upper tract urothelial cancer awareness day

Tyra Biosciences has announced the establishment of Upper Tract Urothelial Cancer (UTUC) Awareness Day, in collaboration with the Bladder Cancer Advocacy Network (BCAN). UTUC is...

Valion Bio briefs senior Department of War and BARDA officials in joint engagement on Entolimod for acute radiation syndrome

Valion Bio, a late-stage innate immunotherapeutics company, has announced that it presented Entolimod for acute radiation syndrome (ARS) to senior officials from the US Department...

Technology and Automation

Bio-Rad launches PTC Harmony 96 and PTC Harmony Deepwell thermal cyclers

Bio-Rad Laboratories has launched the PTC Harmony Thermal Cycler line, designed to offer broader access to optimised workflows for PCR applications such as sequencing,...

PCI Pharma Services announces US$1 billion expansion of US sterile fill-finish and drug-device delivery combination capabilities

PCI Pharma Services, a world-leading integrated global contract development and manufacturing organisation (CDMO) focused on innovative biologic and small molecule therapies, has announced a...

Ledger Run first to bring AI-powered automation to clinical trial payments

Ledger Run, a leader in clinical trial financial management solutions, has announced significant upgrades to its ClinRun platform, including intelligent automation and expanded flexibility to accelerate...

Trelleborg strengthens quality compliance with ISO certification in Costa Rica

Trelleborg Medical Solutions’ manufacturing site in Costa Rica has earned ISO 13485:2016 certification, helping ensure product consistency and compliance. ISO 13485:2016 is a process-focused quality framework...

Liebherr expands UK lab portfolio

Commercial refrigeration specialist Liebherr has introduced seven high performance countertop and fully integrated under bench models in their UK lab and healthcare range. These include...

Pharma packaging and logistics

Alcami to acquire contract packaging organisation Tjoapack

Alcami Corporation, a leading US-based contract development and manufacturing organisation (CDMO), has entered into a definitive agreement to acquire Tjoapack, a leading global contract...

Alcami to acquire contract packaging organisation Tjoapack

Alcami Corporation, a leading US-based contract development and manufacturing organisation (CDMO), has entered into a definitive agreement to acquire Tjoapack, a leading global contract...

PCI Pharma Services announces US$1 billion expansion of US sterile fill-finish and drug-device delivery combination capabilities

PCI Pharma Services, a world-leading integrated global contract development and manufacturing organisation (CDMO) focused on innovative biologic and small molecule therapies, has announced a...

4basebio announces major expansion to support the growing demand of RUO and HQ synthetic DNA with lease of an innovation hub and manufacturing facility...

4basebio PLC, a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, has announced a significant expansion into a new innovation hub...

Delivery routes expanded and order cut-off times for midwest and west coast customers extended

Smith Drug Company, the industry's largest wholesaler dedicated exclusively to independent retail and long-term care pharmacies, has announced a series of operational enhancements designed...

Events and conferences

BIO International 2026

22-25 June San Diego, USA The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with...

5th Oligonucleotide analytical development & CMC Summit

17-19 August in Boston, USA Scaling DNA and large RNA construct production, analytics and quality control for cGMP compliant vaccines, therapeutics and RNA-based cell and...

CDD & AI for Biologics Summit

25-27 August in Boston, USA Latent Labs’ launch to develop biologics using advanced AI models, alongside Eli Lilly’s Tunelab partnering with BigHat Bio and Chai...

BIO-Europe 2026

9-11 November Cologne (Koln), Germany BIO-Europe is Europe’s largest and longest-running partnering conference for the global biotechnology and biopharma industry. The event brings together 5800+...

CPHI and PMEC China 2026

16-18 June | Shanghai New International Expo Center, Shanghai CPHI & PMEC China is Asia’s premier pharmaceutical event for sourcing, networking, learning and innovation with...